France will take a stake in Sanofi's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on ...

The proposed sale turned into a real political issue because Opella's products include Doliprane, the best-selling medicine ...

The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane painkiller will stay in ...

Politicians from across the political spectrum are up in arms over healthcare giant Sanofi's plans to sell France's ...

The French government is seeking job guarantees from drugmaker Sanofi regarding its Doliprane production sites in the event ...

Unions in France are planning a walkout over the planned sale of the pharmaceutical company that makes popular painkiller ...

EDITORIAL. French pharmaceutical company Sanofi's plan to sell 50% of Opella, which produces France's favorite drug, to an ...

France’s Economy Minister has warned that the government could block the sale of a subsidiary of the French pharmaceutical ...

In its revised bid, PAI pledged to preserve headcount and raise investments at Opella's French production sites of Lisieux in Normandy and Compiegne, the source said. It also vowed to keep Opella's ...

The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane painkiller will stay in France to allow the sale of its consumer health branch to go ahead ...

The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane painkiller will stay in France to allow the sale of its consumer health branch to go ahead, ...